ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Adocia

Adocia (ADOC)

6.05
-0.02
( -0.33% )
Updated: 03:35:24

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
6.05
Bid
6.04
Ask
6.10
Volume
18,677
6.05 Day's Range 6.21
5.11 52 Week Range 11.90
Market Cap
Previous Close
6.07
Open
6.11
Last Trade
130
@
6.05
Last Trade Time
03:33:24
Financial Volume
-
VWAP
-
Average Volume (3m)
125,660
Shares Outstanding
14,398,513
Dividend Yield
-
PE Ratio
-4.13
Earnings Per Share (EPS)
-1.47
Revenue
6.05M
Net Profit
-21.16M

About Adocia

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Lyon, Rhone, Fra
Founded
-
Adocia is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ADOC. The last closing price for Adocia was 6.07 €. Over the last year, Adocia shares have traded in a share price range of 5.11 € to 11.90 €.

Adocia currently has 14,398,513 shares outstanding. The market capitalization of Adocia is 87.40 € million. Adocia has a price to earnings ratio (PE ratio) of -4.13.

ADOC Latest News

ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets

Regulatory News: Under the liquidity agreement entrusted by Adocia (Euronext Paris: FR0011184241 – ADOC) to Kepler Capital Markets, the following resources were listed on the liquidity account on...

Number of Shares and Voting Rights of ADOCIA as of December 31st, 2024

Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French « Code de Commerce » and article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers...

ADOCIA Announces Its Participation at Upcoming Investor Conferences in 2025

Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic...

ADOCIA Announces its Financial Calendar for 2025

Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the...

ADOCIA et Tonghua Dongbao annoncent le dernier dosage dans une étude clinique de Phase 3 de BioChaperone® Lispro, étape associée à un paiement de 10 millions de dollars

L'administration de la dernière dose au dernier patient conclut l'étude de Phase 3 chez les personnes atteintes de diabète de Type 2, événement associé à un paiement de 10 millions de dollars de...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.1655629139076.046.885.861366726.20639905DE
40.061.001669449085.996.885.72755726.10206207DE
12-3.05-33.51648351659.110.965.521256607.56715712DE
26-0.31-4.874213836486.3610.965.111130617.45684449DE
52-4.67-43.563432835810.7211.95.111128707.97113973DE
156-1.65-21.42857142867.716.162.745955798.0017867DE
260-9.41-60.866752910715.4616.182.745662488.15287941DE

ADOC - Frequently Asked Questions (FAQ)

What is the current Adocia share price?
The current share price of Adocia is 6.05 €
How many Adocia shares are in issue?
Adocia has 14,398,513 shares in issue
What is the market cap of Adocia?
The market capitalisation of Adocia is EUR 87.4M
What is the 1 year trading range for Adocia share price?
Adocia has traded in the range of 5.11 € to 11.90 € during the past year
What is the PE ratio of Adocia?
The price to earnings ratio of Adocia is -4.13
What is the cash to sales ratio of Adocia?
The cash to sales ratio of Adocia is 14.45
What is the reporting currency for Adocia?
Adocia reports financial results in EUR
What is the latest annual turnover for Adocia?
The latest annual turnover of Adocia is EUR 6.05M
What is the latest annual profit for Adocia?
The latest annual profit of Adocia is EUR -21.16M
What is the registered address of Adocia?
The registered address for Adocia is 115 AVENUE LACASSAGNE, LYON, RHONE, 69003
What is the Adocia website address?
The website address for Adocia is www.adocia.com
Which industry sector does Adocia operate in?
Adocia operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALCYBCybergun
0.0002 €
(100.00%)
24.89M
AELISAelis Farma SA
2.70 €
(17.39%)
1.39k
ALTAILighton
22.00 €
(12.88%)
30.23k
ALCWECharwood Energy SA
2.56 €
(11.30%)
4.15k
ALMUNMunic S.A.
0.71 €
(9.57%)
21.8k
DMSBSDiagnostic Medical Systems
0.0045 €
(-35.71%)
80
GNROGeNeuro SA
0.18 €
(-19.64%)
354.95k
ALARFAdeunis
0.748 €
(-18.70%)
900
ALMDTMedian Technologies
3.82 €
(-18.55%)
262.49k
ALBOOBOOSTHEAT
0.0568 €
(-17.68%)
15.59k
ATOAtos SE
0.0022 €
(4.76%)
68.71M
ALCYBCybergun
0.0002 €
(100.00%)
24.89M
BCPBanco Comercial Portugues SA
0.517 €
(-0.31%)
17.21M
ALVERVergnet
0.0014 €
(0.00%)
9.47M
BIOSBiosenic
0.0048 €
(-4.00%)
3.44M

Discussion

View Full Feed
Wingsjr Wingsjr 5 minutes ago
Thx for this. I’ve shared it on Stocktwits and my discord.
FNMA
benhor benhor 5 minutes ago
$ACON exploding on Pre-Market 

0.0578 +0.0146 33.80%
ACON
benhor benhor 5 minutes ago
$ACON exploding on Pre-Market 

0.0578 +0.0146 33.80%
ACON
CashCowMoo CashCowMoo 6 minutes ago
MDMP still has 469 million shares available to dilute before needing to raise the A/S. A lot of restricted will be coming available in the near future.
MDMP
luckydude777 luckydude777 10 minutes ago
ACON liftoff
ACON
CashCowMoo CashCowMoo 12 minutes ago
Yeah, doesnt look like they were really doing much. Look like they had some land but not major helium production.
RHCCF
Fiberrevo9 Fiberrevo9 13 minutes ago
Considering yesterday's trading session, the different trades, the rising pps, i am convinced that good news will be released next week.
What reassures me too is that, during last week, we had three times a peak to about 0,098, down manipulated as always, to a lower end pps, but more buys an
KBLB
gdog gdog 14 minutes ago
done
NLST
tw0122 tw0122 19 minutes ago
.05 + 15% 3m traded
ACON
Seminole Red Seminole Red 21 minutes ago
Constitutional amendment to allow Trump third term introduced in the House

A Republican House member introduced a resolution to amend the U.S. Constitution to allow President Donald Trump — and any other future president — to be elected to serve a third term.
Rep. Andy Ogles of
Guido2 Guido2 22 minutes ago
Goa. I was born here.
FNMA
MagnetLover MagnetLover 25 minutes ago
No way. Or else he would be too busy Sam Altmanning himself.
FLCX
Peter J Peter J 28 minutes ago
It took .000774 to buy those 774 shares todays. Who does this?Very good Question, Badog. A VERY good question...

May I remind you that most of the times over the last years... it was exactly the other way around!

Now, who did/does this...? And why...?

ERHE
tw0122 tw0122 28 minutes ago
$7.51 still a little left for latecomers just cash it out now 
ALUR
10thMountain 10thMountain 32 minutes ago
Speaking of stair stepping…

https://stockcharts.com/c-sc/sc?s=FDCT&p=D&yr=1&mn=0&dy=0&i=t4669085127c&r=1737710215304
FDCT
RickNagra RickNagra 35 minutes ago
Which part of India are you in ?  I know the place very well.
FNMA
tw0122 tw0122 37 minutes ago
Flip back out .53 will revisit 
BTAI
Peter J Peter J 38 minutes ago
Ntephe and insiders are getting away with violating SEC filing and disclosure requirements, with refusing to hold annual shareholder meetings, and with paying themselves undisclosed amounts from undisclosed sources of revenue.

All very true, sounds like a stock I would like to follow
ERHE
RickNagra RickNagra 41 minutes ago
Oh wow.
DBMM
tw0122 tw0122 44 minutes ago
BTAI .49 on the move in some 
BTAI
Peter J Peter J 46 minutes ago
Couldn't use these shares as collateral to buy a rotisserie chicken at Costco.
Well... that firmly explains his obsession with ERHE... 🤣

The altruist gang has combined between 10 and 20 K ERHC posts...

Strategy, remember... all for the good cause! Don't
ERHE
joeycav11 joeycav11 52 minutes ago
Were so undervalued…
With this revenue a medium biotech company can buy us and multiply there balance sheet by 6 times easy.
Obviously company is not selling cheap
Shake up is coming in pharma dont miss it
Cell therapy is the panacea and proven cures like we possess is t
AMRN
Here Today Here Today 53 minutes ago
Another train of thought is that possibly those patients in the Cohorts 1 & 2 might have been talking to their family and friends about this new drug they are on and the results they are seeing so far causing those family and friends to start researching and looking into the company and drug and the
RNAZ

Your Recent History

Delayed Upgrade Clock